Last update 14 Jun 2025

CD7 targeting UCAR-T cell therapy (PersonGen BioTherapeutics)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
CD7UCAR T, CD7UCARd T, CD7UCARg T
Target
CD7
Action
inhibitors
Mechanism
CD7 inhibitors(T-cell antigen CD7 inhibitors), Gene transference(Gene transference), T lymphocyte replacements
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Peripheral T-Cell Lymphoma
Inactive Indication
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Originator Organization
PersonGen BioTherapeutics (Suzhou) Co., Ltd.PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Active Organization
PersonGen BioTherapeutics (Suzhou) Co., Ltd.PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with CD7 targeting UCAR-T cell therapy (PersonGen BioTherapeutics)
NCT05059912
/ Unknown statusPhase 2IIT
Humanized CD7 CAR T-cell Therapy for R/R CD7+ T Cell Lymphoma
100 Clinical Results associated with CD7 targeting UCAR-T cell therapy (PersonGen BioTherapeutics)
Login to view more data
100 Translational Medicine associated with CD7 targeting UCAR-T cell therapy (PersonGen BioTherapeutics)
Login to view more data
100 Patents (Medical) associated with CD7 targeting UCAR-T cell therapy (PersonGen BioTherapeutics)
Login to view more data
100 Deals associated with CD7 targeting UCAR-T cell therapy (PersonGen BioTherapeutics)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Precursor T-Cell Lymphoblastic Leukemia-LymphomaPhase 1
China
PersonGen BioTherapeutics (Suzhou) Co., Ltd.PersonGen BioTherapeutics (Suzhou) Co., Ltd.
19 May 2020
Peripheral T-Cell LymphomaPreclinical
China
PersonGen BioTherapeutics (Suzhou) Co., Ltd.PersonGen BioTherapeutics (Suzhou) Co., Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free